Tetracycline fiber therapy monitored by DNA probe and cultural methods.
Oligonucleotide DNA probe and selective cultural methods were compared in their ability to monitor 6 putative periodontal pathogens in a study evaluating local tetracycline fiber therapy. Subgingival plaque was sampled from 4 sites in each of 20 subjects. Samples were taken before and after therapy from sites assigned to the following test groups: tetracycline (TC) fiber, scaling and root planing, control fiber, and untreated. Each sample was analyzed by both DNA probe and cultural methods. Total anaerobic cultivable counts, Porphyromonas (Bacteroides) gingivalis and Prevotella intermedia (Bacteroides intermedius) were enumerated on nonselective blood agar. Actinobacillus actinomycetemcomitans, Eikenella corrodens, Fusobacterium nucleatum and Wolinella recta were isolated on selective media. TC fiber therapy and scaling reduced total cultivable counts from an initial value of 1 x 10(7) to approximately 2 x 10(5) following therapy. Total counts at untreated sites and at sites with control fibers did not change from baseline. A. actinomycetemcomitans and E. corrodens were detected more frequently by the cultural method; the other monitored species were detected more frequently by DNA probes than by the cultural methods. Agreements between methods were: 77.2% for A. actinomycetemcomitans; 72.2% for P. intermedia; 75.6% for E. corrodens; 39.4% for F. nucleatum; 35.6% for P. gingivalis; and 68.9% for W. recta. Limitations of the selective cultural methods used probably contributed to the discrepancies for P. gingivalis and F. nucleatum. DNA probe and cultural methods indicated comparable levels of suppression of the monitored species following TC fiber therapy and scaling. The microbiota of control fiber and untreated sites did not appear to be significantly altered by either method.
Maiden
M F
MF
Forsyth Dental Center, Boston, MA.
Tanner
A
A
McArdle
S
S
Najpauer
K
K
Goodson
J M
JM
D000188:Actinobacillus / Q000032:analysis / Q000187:drug effects; D001421:Bacteria, Anaerobic / Q000032:analysis* / Q000187:drug effects; D001439:Bacteroides / Q000032:analysis / Q000187:drug effects; D002478:Cells, Cultured; D015169:Colony Count, Microbial; D015342:DNA Probes; D004269:DNA, Bacterial / Q000032:analysis; D016124:Eikenella corrodens / Q000032:analysis / Q000187:drug effects; D005673:Fusobacterium / Q000032:analysis / Q000187:drug effects; D006090:Gram-Negative Bacteria / Q000032:analysis* / Q000187:drug effects; D006801:Humans; D008826:Microbial Sensitivity Tests; D010510:Periodontal Diseases / Q000188:drug therapy* / Q000382:microbiology*; D011145:Polyvinyls; D012680:Sensitivity and Specificity; D013752:Tetracycline / Q000008:administration & dosage / Q000627:therapeutic use*
D015342:DNA Probes; D004269:DNA, Bacterial; D011145:Polyvinyls; C016438:ethylenevinylacetate copolymer; D013752:Tetracycline